Document:

Exhibit 10.12

  

LONGDUODUO COMPANY LIMITED

419, Floor 4, Comprehensive Building, 

Second Light Hospital, Ordos Street, 

Yuquan District, Hohhot, 

Inner Mongolia, China

 

 Reg. S: Private Offering of Common Stock to Non-U.S. Persons

 

 SUBSCRIPTION AGREEMENT

 

1.  SUBSCRIPTION.
The undersigned subscriber (the “Subscriber”) hereby makes application to purchase the number of shares of common stock specified
in Section 5 hereof (the “Shares”) to be issued by LONGDUODUO COMPANY LIMITED, a Nevada corporation (the “Company”).
The Purchase Price for the Shares will be US$ per Share, as set forth in total in Section 5. The Purchase Price will be paid by wire transfer
upon execution of this Agreement by the Subscriber.

 

2. REPRESENTATIONS
OF SUBSCRIBER. The Subscriber represents and warrants to the Company as follows:

 

		(A)	 The written information provided to the Subscriber regarding
the Company is contained in the 5 page Power Point Presentation dated September 2021 and titled "龙多多健康科技有限公司".
The Subscriber is not relying upon any oral statements by the Company or by any other person or other written information in making the
decision to purchase the Shares.

 

		(B)	 The information provided to the Subscriber about the
Company does not include any information about the Company's financial condition or the financial results of its business operations.
The Subscriber has decided to purchase the Shares without the benefit of that information.

 

		(C)	 The Subscriber (or its principals, if the Subscriber is an entity) has such knowledge and experience in financial and business
matters that he is capable of evaluating the merits and risks of an investment in the Company and of making an informed investment decision.

 

		(D)	 The Subscriber is aware that the books and records of the Company will be available for inspection during this offering, upon
reasonable notice, during business hours at the Company's place of business.

 

		(E)	 The Subscriber has been provided access to any information he requested in evaluating his purchase of the Shares.

 

		(F)	The Subscriber has been presented with the opportunity to ask questions and receive answers from officers of the Company relating
to the terms and conditions of the offering and to obtain any additional information necessary to verify the accuracy of the information
made available to the Subscriber.

 

		(G)	To the best of the Subscriber's knowledge based upon appropriate diligence and investigation: (i) none of the cash or property that
is paid or contributed to the Company by the Subscriber will be derived from, or related to, any activity that is deemed criminal under
United States law or that contravenes any federal, state, foreign or international laws and regulations dealing with money laundering;
and (ii) no contribution or payment to the Company by the Subscriber comes from a source which would cause the Company to be in violation
of the United States Bank Secrecy Act, the United States Money Laundering Control Act of 1986 or the United States International Money
Laundering Abatement and Anti-Terrorist Financing Act of 2001.

 

     

     

    

 

3. ACKNOWLEDGEMENTS BY SUBSCRIBER,
The Subscriber acknowledges that the Subscriber is aware of the following facts:

 

		(A)	The Company's common stock is not listed for trading in the
United States or in any other jurisdiction. Although the Company intends to take action to cause its common stock to become listed for
trading in the United States, factors beyond the control of the Company may delay or prevent the common stock from becoming listed. Unless
the common stock becomes listed for trading, there will be no market on which the Subscriber can resell his Shares.

 

		(B)	If a trading market for the Company's common stock does develop,
it will be a thin market for an indefinite period of time, with little trading and little liquidity. Therefore, it the Subscriber wants
to sell his Shares, there may be no buyer available, or the price offered may be less than the actual value of the Shares.

 

		(C)	There were no shares of the Company's common stock outstanding
prior to the commencement of this offering, and there were no other equity securities issued by the Company. The Company intends to sell
an indefinite number of shares of its common stock in this offering.

 

		(D)	No public agency has expressed an opinion upon the accuracy
or adequacy of any information presented by the Company in connection with this offering or the fairness of the terms of the offering.

 

		(E)	The Company may release confidential information about the Subscriber (and, if the Subscriber is an entity, its record and beneficial
owners) to government authorities, if the Company determines in its sole discretion that it is in the best interest of the Company to
do so or that such release is required by applicable law.

 

4.  NON-U.S.
PERSON. The Company is offering the Shares outside the United States only for purchase by persons who are not U.S. Persons (as
defined in Section 902 of Regulation S promulgated by the Securities and Exchange Commission). The Subscriber represents and warrants
to the Company that the Subscriber is not a U.S. Person and that the following statements are true:

 

		(A)	The Subscriber is not a resident of the United States or
of any territories of the United States and is not a U.S. Person.

 

		(B)	The offer and sale of the Shares has not taken place, and
is not taking place, within the United States of America or its territories or possessions. The offer and sale of the Shares has taken
place, and is taking place in an “offshore transaction,” as such term is defined in Regulation S.

 

    2

     

    

 

		(C)	The Subscriber is not acquiring the Shares for the account
or benefit of any U.S. Person.

 

		(D)	The Subscriber acknowledges and agrees that, pursuant to
the provisions of Regulation S, the Shares cannot be sold, assigned, transferred, conveyed, pledged or otherwise disposed of to any U.S.
Person or within the United States of America or its territories or possessions for a period of one year from and after the purchase
of the Shares, unless the Shares are registered for sale in the United States pursuant to an effective registration statement under the
Securities Act or another exemption from such registration is available. The Subscriber has not engaged in any hedging transactions with
regard to the Shares and will not have a short position in, or other hedged position with respect to, such securities at any time prior
to the expiration of the periods restricted under Regulation S (the “Restricted Periods”).

 

		(E)	The Subscriber has not engaged in any "directed selling
efforts" (as defined in Regulation S) in the United States regarding the Shares, nor has it engaged in any act intended to or that
reasonably might have the effect of preconditioning the U.S. market for the resale of the Shares.

 

		(F)	The Subscriber consents to the placement of a legend on any
certificate or other document evidencing the Shares and understands that the Company will refuse to register any transfer of Shares not
made in accordance with applicable U.S. securities laws.

 

		(G)	The Subscriber is not a “distributor” of securities
nor a dealer in securities. . The Subscriber acknowledges, understands and agrees that, if the Subscriber should be deemed to be a distributor
prior to reselling the Shares to a non-U.S. Person during the Restricted Periods, the Subscriber will send a notice to each new subscriber
of the Shares that such new subscriber is subject to the restrictions of Regulation S during the Restricted Periods;

 

		(H)	The Subscriber is purchasing the Shares as principal for
its own account, for investment purposes only and not with an intent or view towards further sale or distribution. The Subscriber has
not pre-arranged any sale of the Shares to any other person or to return the Shares to the United States securities markets (which includes
short sales and hedging transactions in the United States within the Restricted Periods to be covered by delivery of Shares) and is not
purchasing the Shares as part of any plan or scheme to evade the registration requirements of the Securities Act and has no plans to
enter into any such agreement or arrangement.

 

		(I)	If at any time after the expiration of the Restricted Periods
the Subscriber wishes to transfer or attempts to transfer the Shares to a U.S. Person, the Subscriber agrees to notify the Company if
at such time it is an "affiliate" of the Company or is then acting as an "underwriter," "dealer" or "distributor"
as to such Shares (as such terms are defined in the federal securities laws of the United States or the regulations promulgated thereunder,
including, but not limited to, Regulation S), or if such transfer is being made as part of a plan or scheme to evade the registration
provisions of the Securities Act.

 

5. SHARES SUBSCRIBED FOR.  The undersigned subscribes to purchase the following Shares for the following Purchase Price:

 

	 	_______________ shares of common stock.	 
	 	 	 
	 	$______________ Purchase Price (US$ per share)	 

 

6.  BINDING
EFFECT. This Subscription Agreement is executed this ____ day of __________, 2021, and shall bind the parties hereto and their
respective heirs, executors, administrators, distributees, successors and assigns.

 

    3

     

    

 

 SUBSCRIBER:

 

If the Subscriber is an INDIVIDUAL:

 

		 	
	Print Name	 	Print Name (if joint)
	 	 	 
		 	
	Signature of Purchaser	 	Signature of Joint Purchaser (if any)
	 	 	 
		 	
	Address	 	Address
	 	 	 
	 	 	 
	U.S. Tax ID (if a U.S. resident)	 	 

 

If the Subscriber is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY
COMPANY, TRUST or similar entity:

 

		 	
	Name of Entity	 	Country or State of Organization

 

	By:	 	 	 
	 	Name:	 	 	Address
	 	Title:	 	 	 

 

	 	 	 
	U.S. Tax ID (if any)	 	Address

 

	 	ACCEPTED BY THE COMPANY THIS_____ DAY OF ________________, 2021 LONGDUODUO COMPANY LIMITED
	 	 	 
	 	By:	 
	 	 	Zhang Liang President

 

 

4ex_326549.htm

Exhibit 10.1

January __, 2022

 

BY EMAIL

 

[NAME]

 

Re:         Retention Bonus Opportunity

 

Dear ____:

 

At this time, the Company considers it to be in the best interests of Viveve Medical, Inc. (the “Company”) to promote and preserve the employment of certain employees (the “Specified Employees”). You are a Specified Employee and, therefore, the Company’s has determined that appropriate steps should be taken to reinforce and encourage your continued attention and dedication to your duties and responsibilities during this important period. Accordingly, the Company is pleased to offer you the opportunity to receive a Retention Bonus, subject to the terms and conditions set forth below:

 

1.    Retention Bonus. In exchange for your continued employment as outlined in Section 2 below, you will have the opportunity to earn and receive a cash bonus of [_______], less applicable deductions and withholdings (the “Retention Bonus”). The Company will advance you 50% of the Retention Bonus ($[____________]) on March 31, 2022 and the remaining 50% of the Retention Bonus ($[____________]) on July 31, 2022.

 

2.    Retention Bonus Contingencies. To earn a Retention Bonus, you must remain actively employed by the Company through January 31, 2023 (the “Retention Bonus Date”) and you must perform your job duties in a satisfactory manner, as determined by the Company.  The Company retains the right to prorate the Retention Bonus based on part-time status or a leave of absence. If you terminate your employment with the Company for any reason other than for Good Reason (as defined in the [Insert Title of Employment Agreement] (“Employment Agreement”)), or if the Company terminates your employment for Cause (as defined in the Employment Agreement), in each case prior to the Retention Bonus Date, you will be obligated to fully repay to the Company the gross amount of the Retention Bonus within thirty (30) days of the last day of your employment.

 

3.    At-Will Employment. Nothing in this letter agreement shall be construed to alter the at-will nature of your employment with the Company. This means either you or the Company can end your employment at any time, with or without cause and with or without notice.

 

4.    Integration Clause; Acknowledgement. This letter agreement contains the entire agreement between you and the Company relating to the Retention Bonus Opportunity and supersedes any and all prior agreements and understandings related to any retention bonus compensation. This Agreement cannot be changed or modified except by formal written instrument executed by you and the CEO of the Company or another person authorized by the CEO. By signing below where indicated, you acknowledge and agree that the Retention Bonus is entirely separate from your base compensation as well as from any performance bonus or severance to which you might otherwise be eligible.

 

 

 

 

We hope that this incentive encourages your continued effective commitment to the Company during this important period.

 

IN WITNESS WHEREOF, the undersigned have executed this letter agreement as of the date first above written.

 

AGREED:

 

 

By: _____________________________________

[Company Signatory]

 

 

 

 

________________________________________

[Employee Name]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]